Amarin Corp Plc (AMRN)

[ramfan60]

"Ram. part 2 . Theres plenty of downside risk IMHO"
Totally disagree

"Risk that MITIGATE fails to show any risk reduction using Vascepa to prevent , shorten , reduce effects etc of Covid "
It's a data trial.... there's only anecdotal evidence that effects of Covid were reduced. If not true, disappointing but it's no worse than anything else out there.


"Risk that Kaiser did not continue to dispense Vascepa to these ASCVD patients who should continue to be on Vascepa anyway"
That's always a risk...what changed? That has nothing to do with the MITIGATE results

"Risk that AMRN declined to fund / provide Vascepa beyond the initial 12 mths in the trial and thus lost the opportunity for longer term CV data to support R-IT"
The trial is not about R-IT. It's not powered to prove R-IT. You keep tying it to R-IT and setting some expectation the the sky will fall if the trial doesn't prove out R-IT. You should stop. There is only upside.